Ferring Microbiome U.S.

Continued awareness of the significant toll C. diff takes on patients, families, and healthcare providers is critical to advancing patient care. We thank NJ & MI for their support of #CDiffAwarenessMonth. Learn more: tinyurl.com/4hfud376

We are thrilled to share new data analyses @AmCollegeGastro. Read more: bit.ly/3L9WP9c

Looking forward for #ACG2025! Join us Oct. 24–29 at booth # 536 as we connect with peers and share insights to advance gastroenterology care. Discover more at bit.ly/4h0eOux.

We are excited to present analyses of data at @IDWeekmtg. Read more: bit.ly/3WeVCQk

@IDWeekmtg is almost here! Join us Oct. 19–22 at booth # 413 for four days of learning, collaboration, and insights with ID colleagues and industry leaders. Discover more at bit.ly/42wzoNc. #IDWeek2025 #FerringMicrobiome

We’re getting ready for an action-packed October! Our team is eager to connect at two impactful conferences to learn & share insights from: @IDWeekmtg in Atlanta, GA (10/19-22) ➡️ @AmCollegeGastro Annual Scientific Meeting in Phoenix, AZ (10/24-10/29). #IDWeek2025 #ACG2025

@MTIG_News has filed a Citizen Petition urging the @US_FDA to update its 2022 guidance on FMT. With approved microbiome therapeutics available, it’s time to ensure every patient receives safe, quality-controlled treatment. Read the petition here: bit.ly/4n6fOPO

That's a wrap on @DDWMeeting 2025! Thanks to everyone who attended #DDW2025. We look forward to seeing you next year! #FerringMicrobiome

We are excited to announce new data on our microbiome-based therapeutic for recurrent C. diff infection presented at @ddwmeeting 2025. Read more: bit.ly/4m0KlPh?utm_so… ​ #FerringMicrobiome #DDW2025

Dr. Sahil Khanna, M.B.B.S., M.S., will present findings on symptom improvement and quality of life in adults with recurrent C. diff infection following fecal microbiota administration by colonoscopy @DDWMeeting 2025. ​ Join us at #DDW2025!

We are attending @DDWMeeting in San Diego, CA, where we will be presenting four posters and one oral presentation. Come join us!​ #FerringMicrobiome #DDW2025

The correct answer is reducing good bacteria. Dysbiosis decreases the diversity and volume of beneficial bacteria like Bacteroidetes and Firmicutes in the gut. Learn more about the crucial link between the gut microbiome and CDI: powerofmicrobiome.com.

C. difficile infections (CDI) are often linked to dysbiosis, a disruption of the gut microbiome. How does dysbiosis create a favorable environment for C. diff to grow? Test your knowledge with our #MicrobiomeMonday poll. Dysbiosis promotes CDI by:

Ferring is celebrating the two-year anniversary of its therapeutic to prevent recurrent C. diff infection. Learn more: bit.ly/4jzmkxC

In this #MicrobiomeMonday learn more about what's fact ✅ or fiction ❌ when it comes to C. diff infection. Visit bit.ly/4gQDO7a to learn more.

Boost your #MicrobiomeVocab this #MicrobiomeMonday! Today's word: Intestinal Colonization Resistance. Discover the power of your #microbiome at bit.ly/4gQDO7a.

Did you guess true? Then you are correct! A diverse gut microbiome, rich in various species like Bacteroidetes and Firmicutes, is generally associated with better overall health. To learn more visit, powerofmicrobiome.com.

Test your knowledge with this #MicrobiomeMonday poll. True or False: A diverse gut microbiome is essential for overall health.

This #MicrobiomeMonday, improve your #MicrobiomeVocab and understand the power of your #microbiome at bit.ly/4gQDO7a.

#MicrobiomeMonday: C. diff can disrupt a gut's delicate balance. Testing helps identify the infection and guide the approach to dealing with C. diff. More info: bit.ly/48BAcCj